Sunstone is a leader in the delivery of psychedelic-assisted therapy in the medical setting, focusing on the development and execution of clinical trials today, and moving towards clinical delivery when therapies are approved. We aim to reduce the emotional suffering of those affected by cancer and complex mental health challenges and disorders, and to make safe, effective psychedelic-assisted therapy an accessible reality for all who might benefit from it.
